NASDAQ, INSM - Insmed Inc
We are a development stage company with expertise in recombinant protein drug
development. We have a state-of-the art FDA-approved commercial biologics
manufacturing facility located in Boulder, Colorado, and our corporate office is
located in Richmond, Virginia.
We are pursuing a dual path strategy involving entry into the follow-on
biologics follow-on biologics) arena (also known as biosimilars, biogenerics and
biologics) and advancing our proprietary protein platform into niche markets
with unmet needs. In the follow-on biologics field, we are developing a robust
pipeline of products targeted for markets in anemia, neutropenia and autoimmune
diseases. On the proprietary protein front, our product, the FDA-approved
IPLEX?, is in various stages of development for a number of serious medical
conditions. ...
Read SEC Filing on NASDAQ.com »